about
Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure statusHepatitis B virus: inactive carriersHigh rates of early HBeAg seroconversion and relapse in Indian patients of chronic hepatitis B treated with Lamivudine: results of an open labeled trial.The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide AnalogsProphylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?Hepatitis B Virus Infection, MicroRNAs and Liver DiseaseMicroRNAs may solve the mystery of chronic hepatitis B virus infectionManagement of patients with hepatitis B in special populationsElective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus--a systematic review.Development of a molecular-beacon assay to detect the G1896A precore mutation in hepatitis B virus-infected individuals.Current antiviral therapy for chronic hepatitis B.Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers.Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria.Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population.Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.CD3Z genetic polymorphism in immune response to hepatitis B vaccination in two independent Chinese populationsNew animal models of hepatitis B and C.Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil.Too much of a good thing? When to stop catch-up vaccinationThe role of entecavir in the treatment of chronic hepatitis B.Hepatitis B virus kinetics under antiviral therapy sheds light on differences in hepatitis B e antigen positive and negative infections.Hepatitis B in the Greater San Francisco Bay Area: an integrated programme to respond to a diverse local epidemic.The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis.Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis.Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy.Early detection of hepatitis B drug resistance: implications for patient management.Rapid production of neutralizing antibody leads to transient hepadnavirus infection.Review article: current management of chronic hepatitis B.Abnormal liver test results on routine screening. How to evaluate, when to refer for a biopsy.Entecavir therapy in Turkish adult patients with chronic hepatitis B: one-year results from Izmir province, TurkeyEffects of storage conditions on the stability of serum CD163, NGAL, HMGB1 and MIP2Hepatitis B mother--to--child transmission.The expression of miR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen.Preventing and treating hepatitis B infection.Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.Anti-HBV effect of TAT- HBV targeted ribonuclease.A novel HBV antisense RNA gene delivery system targeting hepatocellular carcinoma.Introduction to chronic hepatitis B infection.New developments in the treatment of chronic hepatitis B.Electronic messages increase hepatitis B screening in at-risk Asian American patients: a randomized, controlled trial
P2860
Q24241852-A29404C3-B5D1-4FE2-B4DA-9C75BA9E2161Q24810833-825C860C-1869-49FD-AB03-B7E1D3DF0120Q24814210-AA30E456-D6C2-4EA4-AB18-60F49F069324Q26781795-90DB7687-45AF-4D3D-A598-5ECB92398E6AQ26781880-6E14256B-3CAE-4D1E-A0F6-C283B5D908C8Q26801511-E503BA88-20E7-4BF9-935F-C90265D856DFQ26827668-3B4E5BA5-6640-4E96-B3E3-785C1D659A30Q27016136-EECF0E01-F1A8-487F-B6AD-217E79321015Q33364553-43ABA566-AEA4-41A4-8A25-4A22D8158256Q33592384-0F1D2E43-41E2-4A06-9262-B347ADEDC5C7Q33631693-5413DE35-488A-41B4-BAD1-E84939C13782Q33671532-A6A9DF4C-CC34-43C7-9C76-E1F698337696Q33751625-C027E3B0-B5E7-4513-B43B-3CE1856EF539Q33905171-99E0BFDC-346C-4628-A9A8-745F42E4BF15Q34232555-9EC8BE3F-AF02-49A4-BDBE-A70DEFB41F42Q34247198-DBEBE673-C258-4D08-9155-5E2029E32120Q34282823-D80E6365-1C8B-4F2C-B145-32E073403416Q34362568-C4BA7B77-10AC-4B11-95BC-96CFF6CDB8D8Q34585496-04E05A6F-1275-474D-AA78-1B5613DAA0D3Q34592640-41DB19A3-F15E-45C4-AABF-6A79B5B83E5EQ34683065-B4DF79C9-F5ED-4018-A638-5AF7C4858BD8Q34891397-724D0A89-3FF5-47FC-A13A-C6D7007CB123Q34907270-B7A6DA32-D1AA-4C0F-974C-CBA217CF45DDQ34985468-F8FD7ED2-CB25-44E6-AB0C-2607069F0B8EQ35152610-2B871D73-5537-4FAA-8297-9FFD095CC1B6Q35543876-AA5CDBA3-3685-40BA-929B-0E57DF94E45FQ35543965-5E9947D6-CC12-4322-9E0D-A1063626B2E2Q35612108-F2C0FAB1-0BA0-45E8-8E1C-7441C9906BB1Q35706654-41B5BEF8-0C46-4725-B4D5-96449101ECDDQ35714962-E25CEE47-E5F7-46B4-B866-5C1EF94EE8F2Q35741156-D08F8F6A-170F-4647-919B-CB286438000BQ35917346-414866C8-4934-481E-AE12-94BB8C2FC296Q35939141-CE0F0779-6FB7-4125-9DC0-1097F79105D9Q35940524-2B185CA1-E549-4185-A0D3-9AC542C244A7Q36075755-63A779D1-395F-423B-B745-235FB9CFC11FQ36190695-AA721C28-F274-4D64-8EB4-33ADD52B6A58Q36209705-AF4F7D63-05AB-44A1-8805-C5E5E869AD79Q36382631-BA272E68-8F76-4B42-B913-16B3912C69D4Q36569744-204DAB9C-1215-4703-88E5-52F40B4BFE5BQ36625726-1E0ED481-B984-4993-9FB1-F967503BDBA8
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hepatitis B: an important public health issue.
@ast
Hepatitis B: an important public health issue.
@en
type
label
Hepatitis B: an important public health issue.
@ast
Hepatitis B: an important public health issue.
@en
prefLabel
Hepatitis B: an important public health issue.
@ast
Hepatitis B: an important public health issue.
@en
P2860
P1476
Hepatitis B: an important public health issue.
@en
P2093
Maddrey WC
P2860
P304
P356
10.1002/1096-9071(200007)61:3<362::AID-JMV14>3.0.CO;2-I
P577
2000-07-01T00:00:00Z